Accurun 140 Rubella Igg Positive Control
FDA 510(k) K972986 · Boston Biomedica, Inc.
510(k) numberK972986
Submission
- Device name
- Accurun 140 Rubella Igg Positive Control
- Applicant
- Boston Biomedica, Inc.
West Bridgewater, MA, US - Received
- August 11, 1997
- Decision date
- October 8, 1997
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MJX – Kit, Serological, Positive Control
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 862.1660
- Specialty
- Clinical Chemistry
Other 510(k)s with product code MJX
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K101434 | Audit Microcv Procalcitonin LinearityMJX · Traditional | Aalto Scientific, Ltd. | 07/22/2010SE |
| K030067 | Vitros Immunodiagnostic Products Hbsag ControlsMJX · Traditional | Ortho-Clinical Diagnostics | 01/17/2003SE |
| K974262 | Syscos Idc - G, Idc, BSC, Idc - GMJX · Traditional | Scantibodies Laboratory, Inc. | 12/24/1997SE |
| K970100 | Tech Simple Syphilis Positive Serum Control Monitor Ontrak Syphilis Positive Serum ControlMJX · Traditional | Simplicity Diagnostics, Inc. | 03/10/1997SE |
| K934137 | Opus(R) Serology Controls, ModificationMJX · Traditional | Pb Diagnostic Systems, Inc. | 03/07/1994SE |
| K925703 | Opus Serology ControlsMJX · Traditional | Pb Diagnostics, Inc. | 04/08/1993SE |
More from Pb Diagnostics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K032713 | Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggLSR · Traditional | 11/24/2003SE |
| K980351 | Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitLSR · Traditional | 03/05/1999SE |
| K974811 | Accurun(Tm) 150 HSV Igg Positive ControlJJX · Traditional | 02/10/1998SE |
| K974810 | Accurun(Tm) 132 Borrelia Burdorferi Igm Positive ControlLSR · Traditional | 02/05/1998SE |
| K974809 | Accurun(Tm) 130 Borrelia Burgdorferi Igg Positive ControlLSR · Traditional | 02/05/1998SE |
| K974261 | Accurun 135 Toxoplasma Igg Positive ControlLJK · Traditional | 12/11/1997SE |
| K972884 | Accurun 146 CMV Igm Positive ControlLKQ · Traditional | 08/22/1997SE |
| K972048 | Accurun 117 Hbeag Positive ControlJJY · Traditional | 08/12/1997SE |
| K971657 | Accurun 121 Hav Igm Positive ControlJJY · Traditional | 08/12/1997SE |
| K972307 | Accurun 119 Anti-Hepatitis B E Antigen (Anti-Hbe) Positive ControlJJY · Traditional | 08/07/1997SE |
Questions and answers
When was Accurun 140 Rubella Igg Positive Control cleared by the FDA?
Accurun 140 Rubella Igg Positive Control (K972986) received a 510(k) decision of Substantially Equivalent on October 8, 1997, 58 days after the submission was received.
What is the product code of K972986?
The FDA product code is MJX – Kit, Serological, Positive Control, a Class I (low risk) device regulated under 21 CFR 862.1660.